Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
"Given the growing body of anecdotal and clinical evidence, I would strongly support expanded research into GLP-1 receptor agonists as a therapeutic tool for addiction
Staying hydrated while taking a GLP-1 is often an overlooked part of the equation, even though proper hydration plays an important role in supporting your overall health during treatment
However, a 145-patient randomised controlled trial (RCT) reported that 4 g of paracetamol daily in divided doses for 4 days was associated with an increase in ALT activity in a significant proportion of patients when compared to placebo, although the clinical significance of this elevation in ALT is unclear [24]
The answer to this question is a YES
We need to see how patients fare over several years, not just several months, to truly understand the risk-benefit profile before we can determine its ultimate place in treatment. Having medications like eloralintide, which work through a different mechanism, may provide a vital alternative and increase our ability to personalize treatment for the individual
US$ 27.85
US$ 21.28
US$ 27.96
